Significant Correlation between Cystatin C, Cerebral Infarction, and Potential Biomarker for Increased Risk of Stroke

Publisher: Bentham Science Publishers

E-ISSN: 1875-5739|12|1|40-46

ISSN: 1567-2026

Source: Current Neurovascular Research, Vol.12, Iss.1, 2015-02, pp. : 40-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

This study investigated the correlation of serum cystatin C levels with cerebral infarction (CI) anddifferent subtypes of CI, the severity of CI and the risk of recurrent CI. Totally 1017 patients with CI and 534healthy controls were included, with clinical and biochemical characteristics documented and analyzed. Theresults showed serum cystatin C were 0.93 plusmn; 0.21 mg/l and 1.19 plusmn; 0.5 mg/l in control and CI, respectively (plt; 0.001). The significant risk factors for CI were age (p lt; 0.001, OR = 1.048), presence of diabetes (p =0.007, OR = 2.397), cystatin C (p = 0.001, OR = 1.021), uric acid (p = 0.017, OR = 4.226), and systolic blood pressure (p= 0.021, OR = 1.003). The risk of CI increased with cystatin C levels. Also, cystatin C levels were associated withdifferent subtypes of CI, with large-artery atherosclerosis (LAA) subtype having the highest level of cystatin C. Moreover,cystatin C levels were significantly and positively correlated with Essen Stroke Risk Score (ESRS). The higher level ofcystatin C the higher risk of recurrent stroke. In contrast, correlation between cystatin C levels and National Institute ofHealth stroke scale (NIHSS) score was not significant. In conclusion, cystatin C was an independent risk factor for CI.LAA subtype of CI was more closely related to increased cystatin C level. Furthermore, cystatin C levels predict risk ofrecurrent CI but not the severity of CI.

Related content